Abstract:Research ethics: Not applicable as this is an internal laboratory investigation. Informed consent: Informed consent was obtained from all individuals included in this study, or their legal guardians or wards. Author contributions: Conceptualization: Lee CK, Koay ESK, Tan M, and Loh TP; Methodology: Lee CK, Huan PT, Chai CN, Ng LJ, Lee OF, and Loh TP; Validation: Lee CK and Loh TP; Formal analysis: Lee CK and Lee OF; Investigation: Lee CK, Huan PT, Chai CN, Ng LJ, Lee OF, and Loh TP; Resources: Lee CK, Koay ESK, Tan M, and Loh TP. Data curation: Lee CK; Writing – original draft preparation: Lee CK, Lee OF, Tan M, and Loh TP; Writing – review and editing: all authors; Visualization: Lee OF; Supervision: Lee CK; Project administration: Lee CK, Koay ESK, and Loh TP. The authors have accepted responsibility for the entire content of this manuscript and approved its submission. We affirm that the material is original research, has not been previously published and has not been submitted for publication elsewhere while under consideration. Competing interests: The authors state no conflict of interest. Research funding: None declared. Data availability: The raw data can be obtained on request from the corresponding author. 1. Lennard, L, Van Loon, JA, Weinshilboum, RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989;46:149–54. https://doi.org/10.1038/clpt.1989.119. Search in Google Scholar PubMed 2. Abaji, R, Krajinovic, M. Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response. Pharmgenomics Pers Med 2017;10:143–56. https://doi.org/10.2147/pgpm.s108123. Search in Google Scholar PubMed PubMed Central 3. Lee, CK, Loh, TP, Wong, ST, Lee, HK, Huan, PT, Chiu, LL, et al.. Detection of a novel single nucleotide polymorphism of the human thiopurine s-methyltransferase gene in a Chinese individual. Drug Metabol Pharmacokinet 2012;27:559–61. https://doi.org/10.2133/dmpk.dmpk-12-sc-008. Search in Google Scholar PubMed 4. Lee, CK, Lee, HK, Huan, PT, Chiu, LL, Loh, TP, Koay, ESC. A point mutation in the thiopurine S-methyltransferase gene that led to exon 5 deletion in the transcribed mRNA. Clin Chem Lab Med 2016;54:e301–3. https://doi.org/10.1515/cclm-2015-1170. Search in Google Scholar PubMed 5. Otterness, DM, Szumlanski, CL, Wood, TC, Weinshilboum, RM. Human thiopurine methyltransferase pharmacogenetics. Kindred with a terminal exon splice junction mutation that results in loss of activity. J Clin Invest 1998;101:1036–44. https://doi.org/10.1172/jci1004. Search in Google Scholar PubMed PubMed Central 6. Lee, D, Szumlanski, C, Houtman, J, Honchel, R, Rojas, K, Overhauser, J, et al.. Thiopurine methyltransferase pharmacogenetics. Cloning of human liver cDNA and a processed pseudogene on human chromosome 18q21.1. Drug Metab Dispos 1995;23:398–405. Search in Google Scholar 7. Kham, SKY, Soh, CK, Aw, DCW, Yeoh, AEJ. TPMT*26 (208F-->L), a novel mutation detected in a Chinese. Br J Clin Pharmacol 2009;68:120–3. https://doi.org/10.1111/j.1365-2125.2009.03405.x. Search in Google Scholar PubMed PubMed Central 8. Collie-Duguid, ES, Pritchard, SC, Powrie, RH, Sludden, J, Collier, DA, Li, T, et al.. The frequency and distribution of thiopurine methyltransferase alleles in caucasian and Asian populations. Pharmacogenetics 1999;9:37–42. https://doi.org/10.1097/00008571-199902000-00006. Search in Google Scholar PubMed © 2024 Walter de Gruyter GmbH, Berlin/Boston

A 6 Bp Deletion Polymorphism in the 3’UTR of the Human Thymidylate Synthase Gene Causes Message Instability and is Associated with Decreased Intratumoral TS Mrna Levels

Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis.

Mutation Analysis of Novel Human Liver-Related Putative Tumor Suppressor Gene in Hepatocellular Carcinoma

Deletion of the MTO2 gene related to tRNA modification causes a failure in mitochondrial RNA metabolism in the yeast Saccharomyces cerevisiae.

Compound Hemizygous Variants in SERPINA7 Gene Cause Thyroxine-Binding Globulin Deficiency

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

Polymorphisms in the enhancer region of the thymidylate synthase gene are associated with thymidylate synthase levels in normal tissues but not in malignant tissues of patients with colorectal cancer

[Analysis of Gene Mutation in Patients with Tuberous Sclerosis Complex with Polymerase Chain Reaction-Single Strand Conformation Polymorphism].

[Genetic Analysis of a Mosaic Case with Low Proportion Mutation of TSC2 Gene].

A large deletion in TSC2 causes tuberous sclerosis complex by dysregulating PI3K/AKT/mTOR signaling pathway

Cortisol levels in central adrenal insufficiency: light and shade.

Polymorphism of thymidylate synthase gene and chemosensitivity of 5-fluorouracil regimen in metastatic gastrointestinal cancer

A natural non-Watson-Crick base pair in human mitochondrial tRNAThr causes structural and functional susceptibility to local mutations.

Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Novel TSC2 Mutations and Decreased Expression of Tuberin in Cultured Tumor Cells with an Insertion Mutation

Polymorphisms in Thymidylate Synthase Gene and Susceptibility to Breast Cancer in a Chinese Population: a Case-Control Analysis

Taurine hypomodification underlies mitochondrial tRNATrp-related genetic diseases

Novel thiopurine S-methyltransferase ( TPMT ) variant identified in Malay individuals

rTS gene expression is associated with altered cell sensitivity to thymidylate synthase inhibitors

Detection of Thymidylate Synthase Modulators by a Novel Screening Assay.

Effect of 3′UTR RET Variants on RET mRNA Secondary Structure and Disease Presentation in Medullary Thyroid Carcinoma